Home >  News >  March, 2018

Study Finds Psychosis Drug Amisulpride Reduces Nausea and Vomiting

Small doses of amisulpride, a drug used to manage psychosis, may prevent PONV when given with standard anti-nausea treatment, say researchers.

Published: March 16, 2018

Nausea FEELING QUEASY Researchers believe a common anti-psychosis drug could have prevented this patient's post-operative nausea.

Patients given a small intraoperative dose of an antipsychotic medication used to treat schizophrenia along with a common anti-nausea drug had significantly less post-operative nausea and vomiting (PONV) than patients given a placebo, reports a study in the American Society of Anesthesiologists' Online First edition of Anesthesiology.

Amisulpride, sold under the brand name Solian, is commonly used in Europe to manage psychosis and is currently under review by the U.S. Food and Drug Administration. The drug works by blocking dopamine signaling without inducing the irregular heart rhythms and drug-induced movement disorders that occurred when similar drugs were used to control nausea and vomiting in the past.

Researchers in Europe and the United States conducted a double-blind placebo-controlled study where patients with high-risk of PONV were given an anti-nausea drug (usually ondansetron or dexamethasone) along with 5mg of intravenously delivered amisulpride or a placebo. More than half (58%) of patients given amisulpride had no vomiting or need for fast-acting medication to prevent vomiting 24 hours after surgery. All PONV occurrences were lower in the amisulpride group. Only 14% had vomiting compared to 20% in the placebo, 50% had any nausea compared to 58% in the placebo, 37% had significant nausea compared to 48% in the placebo and 41% required fast-acting medication to stop vomiting compared to 49% in the placebo.

"This could enable improved control of PONV and allow for earlier mobilization and discharge of surgical patients," says lead author Peter Kranke, MD, in the ASA press release. "Patients with multiple risk factors for PONV require a multimodal approach for its prevention, including using a combination of anti-nausea drugs with different mechanisms of action, since it cannot be predicted which pathways will be active in a patient."

JoEllen McBride, PhD

Also in the News...

Senator Creates Firestorm With Nurses Playing Cards Comment
Suspect Logged Into Electronic Prescription Program as Ophthalmologist to Fraudulently Issue Opioid Scripts
Marijuana Users May Need Higher Doses of Sedatives Before Endoscopy
Brainlab Recalls Spine & Trauma 3D Navigation 1.0 Software Due to Display Inaccuracies
FDA Orders Withdrawal Of Transvaginal Surgical Mesh From Market
Lawsuit: When PACU Lights Dimmed, Doc Asked Wife to Hold Penlight on Her Husband's Leaking JP Drain
R.I. Smoke Evacuation Legislation Becomes Law

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

Opioid Misuse Among the Year's Top Safety Concerns

News & Notes

Surgery Center Administrator Caught Selling Stolen Medical Devices on eBay